Relmada Therapeutics Inc
NASDAQ:RLMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Barrick Mining Corp
F:ABR0
|
CA |
|
E
|
ENGIE Energia Chile SA
SGO:ECL
|
CL |
|
S
|
SAP SE
SWB:SAPA
|
DE |
|
Intertrust NV
F:4IT
|
NL |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
US |
|
Mobilezone Holding AG
SIX:MOZN
|
CH |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
US |
|
S
|
Spentex Industries Ltd
NSE:SPENTEX
|
IN |
|
BlackRock Inc
NYSE:BLK
|
US |
|
Advantest Corp
OTC:ADTTF
|
JP |
|
Edgewell Personal Care Co
NYSE:EPC
|
US |
|
Matas A/S
CSE:MATAS
|
DK |
|
Hong Kong and China Gas Co Ltd
HKEX:3
|
HK |
|
Montrose Environmental Group Inc
NYSE:MEG
|
US |
|
Samsung Electronics Co Ltd
F:SSU
|
KR |
|
G
|
General Dynamics Corp
XHAM:GDX
|
US |
|
Planet Fitness Inc
NYSE:PLNT
|
US |
|
P
|
Postal Savings Bank of China Co Ltd
OTC:PSBKF
|
CN |
|
N
|
Norditek Group AB
F:O5D
|
SE |
Bankruptcy Probability
Relmada Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Relmada Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
778.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
949.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
555.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
211.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
280.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Relmada Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Relmada Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
